The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: Progress and perspectives

Future Microbiology

Volumn 8, Issue 1, 2013, Pages 73-84

  Wiles, Travis J ^a   Mulvey, Matthew A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; evolution; HlyA; host response; membrane repair; mesotrypsin; pore forming toxin; UPEC; urinary tract infection; uropathogenic Escherichia coli

Indexed keywords

ALPHA HEMOLYSIN; PORE FORMING CYTOTOXIC PROTEIN;

CELL SPECIFICITY; CHANNEL GATING; CYTOLYSIS; HOST PATHOGEN INTERACTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ANIMALS; BACTERIAL TOXINS; HEMOLYSIN PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; UROPATHOGENIC ESCHERICHIA COLI;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84871443752     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.131     Document Type: Review

References (102)

1. Iacovache I, van der Goot FG, Pernot L. Pore formation: An ancient yet complex form of attack. Biochim. Biophys. Acta 1778 1611-1623 (2008
2. Linhartová I, Bumba L, Mašín J et al. RTX proteins: A highly diverse family secreted by a common mechanism. FEMS Microbiol. Rev. 34, 1076-1112 (2010
3. Vigil PD, Wiles TJ, Engstrom MD, Prasov L, Mulvey MA, Mobley HLT. The repeat-in-Toxin family member TosA mediates adherence of uropathogenic Escherichia coli and survival during bacteremia. Infect. Immun. 80, 493-505 (2012
4. Welch RA. Pore-forming cytolysins of Gram-negative bacteria. Mol. Microbiol. 5, 521-528 (1991
5. Welch RA. RTX toxin structure and function: A story of numerous anomalies and few analogies in toxin biology. Curr. Top. Microbiol. Immunol. 257, 85-111 (2001
6. Cavalieri SJ, Bohach GA, Snyder IS. Escherichia coli alpha-hemolysin: Characteristics and probable role in pathogenicity. Microbiol. Rev. 48, 326-343 (1984
7. Haddon J. IV. A case of catheter fever. Ann. Surg. 2, 239-245 (1885
8. Park R. III. The importance to the surgeon of familiarity with the Bacillus coli communis. Ann. Surg. 18, 293-312 (1893
9. Maxwell JL. The relation of Bacillus coli communis to other organisms in the urine. BMJ 2, 1472-1473 (1899
10. Moore VA. Bacillus coli communis. Public Health Pap. Rep. 28, 397-401 (1902
11. Eastes GL. Certain infections of the urinary tract, with special reference to tubercle, gonococcus, and Bacillus coli communis. BMJ 1, 980-982 (1908
12. Dudgeon LS, Ross AV. Infections of the urinary tract due to Bacillus coli and allied organisms: Further observations on the treatment of acute and chronic conditions. Ann. Surg. 51, 355-361 (1910
13. Russo TA, Johnson Jr. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J. Infect. Dis. 181, 1753-1754 (2000
14. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2, 123-140 (2004
15. Wiles TJ, Kulesus RR, Mulvey MA. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 85, 11-19 (2008
16. Foxman B. The epidemiology of urinary tract infection. Nat. Rev. Urol. 7(12), 653-660 (2010
17. Lyon MW. A case of cystitis caused by Bacillus coli-hemolyticus. JAMA LXIX(16), 1342-1343 (1917
18. Dudgeon LS, Wordley E, Bawtree F. On Bacillus coli infections of the urinary tract, especially in relation to haemolytic organisms. J. Hyg. 20, 137-164 (1921
19. Dudgeon LS. Acute infection of the urinary tract due to a special group of haemolytic bacilli. J. Hyg. 22, 348-354 (1924
20. Dudgeon LS, Pulvertaft RJ. On slow lactose fermenting B. coli in urinary and intestinal infections. J. Hyg. 26, 285-304 (1927
21. Cooke EM, Ewins SP. Properties of strains of Escherichia coli isolated from a variety of sources. J. Med. Microbiol. 8, 107-111 (1975
22. Lovell R, Rees TA. A filterable haemolysin from Escherichia coli. Nature 188, 755-756 (1960
23. Smith HW. The haemolysins ofEscherichia coli. J. Pathol. Bacteriol. 85, 197-211 (1963
24. Chaturvedi UC, Mathur A, Khan AM, Mehrotra RM. Cytotoxicity of filtrates of haemolytic Escherichia coli. J. Med. Microbiol. 2, 211-218 (1969
25. Van Den Bosch JF, Postma P, De Graaff J, Maclaren DM. Haemolysis by urinary Escherichia coli and virulence in mice. J. Med. Microbiol. 14, 321-331 (1981
26. Welch RA, Dellinger EP, Minshew B, Falkow S. Haemolysin contributes to virulence of extra-intestinal E. coli infections. Nature 294, 665-667 (1981
27. Frey J. Genetics and phylogeny of RTX cytolysins. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Popoff MR, Alouf JE (Eds). Elsevier Academic Press, UK, 570-577 (2006
28. Ludwig A, Goebel W. Structure and mode of action of RTX toxins. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Popoff MR, Alouf JE (Eds). Elsevier Academic Press, UK, 547-569 (2006
29. Sánchez-Magraner L, Viguera AR, García- Pacios M et al. The calcium-binding C-Terminal domain of Escherichia coli alpha-hemolysin is a major determinant in the surface-active properties of the protein. J. Biol. Chem. 282, 11827-11835 (2007
30. Sánchez-Magraner L, Cortajarena AL, García- Pacios M et al. Interdomain Ca2+ effects in Escherichia coli alpha-haemolysin: Ca2+ binding to the C-Terminal domain stabilizes both C- And N-Terminal domains. Biochim. Biophys. Acta 1798, 1225-1233 (2010
31. Schindel C, Zitzer A, Schulte B et al. Interaction of Escherichia coli hemolysin with biological membranes. A study using cysteine scanning mutagenesis. Eur. J. Biochem. 268, 800-808 (2001
32. Soloaga A, Veiga MP, García-Segura LM, Ostolaza H, Brasseur R, Goñi FM. Insertion of Escherichia coli alpha-haemolysin in lipid bilayers as a non-Transmembrane integral protein: Prediction and experiment. Mol. Microbiol. 31, 1013-1024 (1999
33. Valeva A, Siegel I, Wylenzek M et al. Putative identification of an amphipathic alpha-helical sequence in hemolysin of Escherichia coli (HlyA) involved in transmembrane pore formation. Biol. Chem. 389, 1201-1207 (2008
34. Hyland C, Vuillard L, Hughes C, Koronakis V. Membrane interaction of Escherichia coli hemolysin: Flotation and insertion-dependent labeling by phospholipid vesicles. J. Bacteriol. 183, 5364-5370 (2001
35. Forestier C, Welch RA. Identification of RTX toxin target cell specificity domains by use of hybrid genes. Infect. Immun. 59, 4212-4220 (1991
36. Stanley P, Packman LC, Koronakis V, Hughes C. Fatty acylation of two internal lysine residues required for the toxic activity of Escherichia coli hemolysin. Science 266, 1992-1996 (1994
37. Stanley P, Koronakis V, Hughes C. Acylation of Escherichia coli hemolysin: A unique protein lipidation mechanism underlying toxin function. Microbiol. Mol. Biol. Rev. 62, 309-333 (1998
38. Herlax V, Maté S, Rimoldi O, Bakás L. Relevance of fatty acid covalently bound to Escherichia coli alpha-hemolysin and membrane microdomains in the oligomerization process. J. Biol. Chem. 284, 25199-25210 (2009
39. Herlax V, Bakas L. Fatty acids covalently bound to alpha-hemolysin of Escherichia coli are involved in the molten globule conformation: Implication of disordered regions in binding promiscuity. Biochemistry 46, 5177-5184 (2007
40. Goebel W, Schrempf H. Isolation and characterization of supercoiled circular deoxyribonucleic acid from beta-hemolytic strains of Escherichia coli. J. Bacteriol. 106, 311-317 (1971
41. Rennie RP, Arbuthnott JP. Partial characterisation of Escherichia coli haemolysin. J. Med. Microbiol. 7, 179-188 (1974
42. Muller D, Hughes C, Goebel W. Relationship between plasmid and chromosomal hemolysin determinants of Escherichia coli. J. Bacteriol. 153, 846-851 (1983
43. Gal-Mor O, Finlay BB. Pathogenicity islands: A molecular toolbox for bacterial virulence. Cell Microbiol. 8, 1707-1719 (2006
44. Juhas M, van der Meer JR, Gaillard M, Harding RM, Hood DW, Crook DW. Genomic islands: Tools of bacterial horizontal gene transfer and evolution. FEMS Microbiol. Rev. 33, 376-393 (2009
45. Frey J, Kuhnert P. RTX toxins in Pasteurellaceae. Int. J. Med. Microbiol. 292, 149-158 (2002
46. Burgos Y, Beutin L. Common origin of plasmid encoded alpha-hemolysin genes in Escherichia coli. BMC Microbiol. 10, 193 (2010
47. Strathdee CA, Lo RY. Extensive homology between the leukotoxin of Pasteurella haemolytica A1 and the alpha-hemolysin of Escherichia coli. Infect. Immun. 55, 3233-3236 (1987
48. Koronakis V, Cross M, Senior B, Koronakis E, Hughes C. The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli. J. Bacteriol. 169, 1509-1515 (1987
49. Eberspächer B, Hugo F, Pohl M, Bhakdi S. Functional similarity between the haemolysins of Escherichia coli and Morganella morganii. J. Med. Microbiol. 33, 165-170 (1990
50. Frey J. The role of RTX toxins in host specificity of animal pathogenic Pasteurellaceae. Vet. Microbiol. 153, 51-58 (2011
51. Gadeberg OV, Orskov I, Rhodes JM. Cytotoxic effect of an alpha-hemolytic Escherichia coli strain on human blood monocytes and granulocytes in vitro. Infect. Immun. 41, 358-364 (1983
52. Keane WF, Welch R, Gekker G, Peterson PK. Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells. Am. J. Pathol. 126, 350-357 (1987
53. Wiles TJ, Dhakal BK, Eto DS, Mulvey MA. Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins. Mol. Biol. Cell 19, 1427-1438 (2008
54. Lally ET, Hill RB, Kieba IR, Korostoff J. The interaction between RTX toxins and target cells. Trends Microbiol. 7, 356-361 (1999
55. Lally ET, Kieba IR, Sato A et al. RTX toxins recognize a beta2 integrin on the surface of human target cells. J. Biol. Chem. 272, 30463-30469 (1997
56. Dileepan T, Kachlany SC, Balashova NV, Patel J, Maheswaran SK. Human CD18 is the functional receptor for Aggregatibacter actinomycetemcomitans leukotoxin. Infect. Immun. 75, 4851-4856 (2007
57. Dileepan T, Kannan MS, Walcheck B, Thumbikat P, Maheswaran SK. Mapping of the binding site for Mannheimia haemolytica leukotoxin within bovine CD18. Infect. Immun. 73, 5233-5237 (2005
58. Cortajarena AL, Goni FM, Ostolaza H. A receptor-binding region in Escherichia coli alpha-haemolysin. J. Biol. Chem. 278, 19159-19163 (2003
59. Cortajarena AL, Goñi FM, Ostolaza H. Glycophorin as a receptor for Escherichia coli alpha-hemolysin in erythrocytes. J. Biol. Chem. 276, 12513-12519 (2001
60. Martin C, Requero MA, Masin J et al. Membrane restructuring by Bordetella pertussis adenylate cyclase toxin, a member of the RTX toxin family. J. Bacteriol. 186(12), 3760-3765 (2004
61. Benz R, Schmid A, Wagner W, Goebel W. Pore formation by the Escherichia coli hemolysin: Evidence for an association-dissociation equilibrium of the pore-forming aggregates. Infect. Immun. 57, 887-895 (1989
62. Ostolaza H, Bartolomé B, Ortiz De Zárate I, De La Cruz F, Goñi FM. Release of lipid vesicle contents by the bacterial protein toxin alpha-haemolysin. Biochim. Biophys. Acta 1147, 81-88 (1993
63. Bhakdi S, Greulich S, Muhly M et al. Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes. J. Exp. Med. 169, 737-754 (1989
64. Wiles TJ, Bower JM, Redd MJ, Mulvey MA. Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli. Plos Pathog. 5, e1000697 (2009
65. Bhakdi S, Mackman N, Nicaud JM, Holland IB. Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores. Infect. Immun. 52, 63-69 (1986
66. Moayeri M, Welch RA. Effects of temperature, time, and toxin concentration on lesion formation by the Escherichia coli hemolysin. Infect. Immun. 62, 4124-4134 (1994
67. Ostolaza H, Bakás L, Goñi FM. Balance of electrostatic and hydrophobic interactions in the lysis of model membranes by E. coli alpha-haemolysin. J. Membr. Biol. 158, 137-145 (1997
68. Bakás L, Ostolaza H, Vaz WL, Goñi FM. Reversible adsorption and nonreversible insertion of Escherichia coli alpha-hemolysin into lipid bilayers. Biophys. J. 71, 1869-1876 (1996
69. Bakás L, Chanturiya A, Herlax V, Zimmerberg J. Paradoxical lipid dependence of pores formed by the Escherichia coli alpha-hemolysin in planar phospholipid bilayer membranes. Biophys. J. 91, 3748-3755 (2006
70. Russo TA, Davidson BA, Genagon SA et al. E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L207-L216 (2005
71. Korostoff J, Wang JF, Kieba I, Miller M, Shenker BJ, Lally ET. Actinobacillus actinomycetemcomitans leukotoxin induces apoptosis in HL-60 cells. Infect. Immun. 66, 4474-4483 (1998
72. Ohguchi M, Ishisaki A, Okahashi N et al. Actinobacillus actinomycetemcomitans toxin induces both cell cycle arrest in the G2/M phase and apoptosis. Infect. Immun. 66, 5980-5987 (1998
73. Stevens PK, Czuprynski CJ. Pasteurella haemolytica leukotoxin induces bovine leukocytes to undergo morphologic changes consistent with apoptosis in vitro. Infect. Immun. 64, 2687-2694 (1996
74. Khelef N, Guiso N. Induction of macrophage apoptosis by Bordetella pertussis adenylate cyclase-hemolysin. FEMS Microbiol. Lett. 134, 27-32 (1995
75. Skals M, Leipziger J, Praetorius HA. Haemolysis induced by alpha-Toxin from Staphylococcus aureus requires P2X receptor activation. Pflugers Arch. 462(5), 669-679 (2011
76. Munksgaard PS, Vorup-Jensen T, Reinholdt J et al. Leukotoxin from Aggregatibacter actinomycetemcomitans causes shrinkage and P2X receptor-dependent lysis of human erythrocytes. Cell Microbiol. 14(12), 1904-1920 (2012
77. Larsen CK, Skals M, Wang T, Cheema MU, Leipziger J, Praetorius HA. Python erythrocytes are resistant to alpha-hemolysin from Escherichia coli. J. Membr. Biol. 244(3), 131-140 (2011
78. Dhakal BK, Mulvey MA. The UPEC pore-forming toxin a-hemolysin triggers proteolysis of host proteins to disruPTcell adhesion, inflammatory, and survival pathways. Cell Host Microbe 11, 58-69 (2012
79. Seeger W, Walter H, Suttorp N, Muhly M, Bhakdi S. Thromboxane-mediated hypertension and vascular leakage evoked by low doses of Escherichia coli hemolysin in rabbit lungs. J. Clin. Invest. 84, 220-227 (1989
80. Bhakdi S, Muhly M, Korom S, Schmidt G. Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release. J. Clin. Invest. 85, 1746-1753 (1990
81. Grimminger F, Walmrath D, Birkemeyer RG, Bhakdi S, Seeger W. Leukotriene and hydroxyeicosatetraenoic acid generation elicited by low doses of Escherichia coli hemolysin in rabbit lungs. Infect. Immun. 58, 2659-2663 (1990
82. Bhakdi S, Martin E. Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin. Infect. Immun. 59, 2955-2962 (1991
83. König B, Ludwig A, Goebel W, König W. Pore formation by the Escherichia coli alpha-hemolysin: Role for mediator release from human inflammatory cells. Infect. Immun. 62, 4611-4617 (1994
84. Bischofberger M, Gonzalez MR, van der Goot FG. Membrane injury by pore-forming proteins. Curr. Opin. Cell Biol. 21, 589-595 (2009
85. Sanchez S, Bakás L, Gratton E, Herlax V. Alpha hemolysin induces an increase of erythrocytes calcium: A FLIM 2-photon phasor analysis approach. Plos One 6, e21127 (2011
86. Koschinski A, Repp H, Unver B et al. Why Escherichia coli alpha-hemolysin induces calcium oscillations in mammalian cells - The pore is on its own. FASEB J. 20, 973-975 (2006
87. Tam C, Idone V, Devlin C et al. Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair. J. Cell Biol. 189, 1027-1038 (2010
88. Idone V, Tam C, Goss JW, Toomre D, Pypaert M, Andrews NW. Repair of injured plasma membrane by rapid Ca2+-dependent endocytosis. J. Cell Biol. 180, 905-914 (2008
89. Valeva A, Walev I, Gerber A, Klein J, Palmer M, Bhakdi S. Staphylococcal alpha-Toxin: Repair of a calcium-impermeable pore in the target cell membrane. Mol. Microbiol. 36(2), 467-476 (2000
90. Husmann M, Beckmann E, Boller K et al. Elimination of a bacterial pore-forming toxin by sequential endocytosis and exocytosis. FEBS Lett. 583, 337-344 (2009
91. Kloft N, Busch T, Neukirch C et al. Pore-forming toxins activate MAPK p38 by causing loss of cellular potassium. Biochem. Biophys. Res. Commun. 385, 503-506 (2009
92. Gonzalez MR, Bischofberger M, Frêche B, Ho S, Parton RG, van der Goot FG. Pore-forming toxins induce multiple cellular responses promoting survival. Cell Microbiol. 13, 1026-1043 (2011
93. Gurcel L, Abrami L, Girardin S, Tschopp J, van der Goot FG. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126, 1135-1145 (2006
94. Sibelius U, Grandel U, Buerke M et al. Leukotriene-mediated coronary vasoconstriction and loss of myocardial contractility evoked by low doses of Escherichia coli hemolysin in perfused rat hearts. Crit. Care Med. 31(3), 683-688 (2003
95. Grimminger F, Sibelius U, Bhakdi S, Suttorp N, Seeger W. Escherichia coli hemolysin is a potent inductor of phosphoinositide hydrolysis and related metabolic responses in human neutrophils. J. Clin. Invest. 88, 1531-1539 (1991
96. Kao C-Y, Los FCO, Huffman DL et al. Global functional analyses of cellular responses to pore-forming toxins. Plos Pathog. 7, e1001314 (2011
97. Bhushan S, Hossain H, Lu Y et al. Uropathogenic E. coli induce different immune response in testicular and peritoneal macrophages: Implications for testicular immune privilege. Plos One 6, e28452 (2011
98. Hilbert DW, Paulish-Miller TE, Tan CK et al. Clinical Escherichia coli isolates utilize alpha-hemolysin to inhibit in vitro epithelial cytokine production. Microbes Infect. 14(7-8), 628-638 (2012
99. König B, König W. Induction and suppression of cytokine release (tumour necrosis factor-alpha; interleukin-6, interleukin-1 beta) by Escherichia coli pathogenicity factors (adhesions, alpha-haemolysin). Immunology 78, 526-533 (1993
100. Smith YC, Rasmussen SB, Grande KK, Conran RM, O'Brien AD. Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. Infect. Immun. 76, 2978-2990 (2008
101. Sheshko V, Hejnova J, Rehakova Z et al. HlyA knock out yields a safer Escherichia coli A0 34/86 variant with unaffected colonization capacity in piglets. FEMS Immunol. Med. Microbiol. 48, 257-266 (2006
102. Haugen BJ, Pellett S, Redford P, Hamilton HL, Roesch PL, Welch RA. In vivo gene expression analysis identifies genes required for enhanced colonization of the mouse urinary tract by uropathogenic Escherichia coli strain CFT073 dsdA. Infect. Immun. 75, 278-289 (2007